Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Natalia D Prihoda"'
Autor:
Ochirbat Batbold, Larisa V. Yurchenko, Dmytro Butov, Mikola E Kovolev, Vika Borisova, Hanna Stepanenko, Nina I. Sokolenko, Elena A. Grinishina, Natalia D Prihoda, Ariungerel Tseveendorj, Alan A. Reid, Khaliunaa Baasanjav, Uyanga Batbold, Narantsetseg Damdinpurev, Tetyana Butova, Satria A. Prabowo, Munkhburam Sanjagdorj, John Lawson Stanford, Allen I Bain, Erkhemtsetseg Chunt, Cynthia Ann Stanford, Vichai Jirathitikal, Natalia I. Makeeva, Olga Arzhanova, Aldar S. Bourinbaiar, Peter Nyasulu, Yuri V Efremenko, Valeryi Kalashnikov, Marina G Tarakanovskaya, Otgonbayar Mijiddorj
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 18, Iss, Pp-(2020)
Objective: Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed Mycobacterium vaccae (NCTC 11659) has been demonstrated in prior clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7acdac0dc919971d1ae6156f009f0b09
https://doi.org/10.1016/j.jctube.2019.100141
https://doi.org/10.1016/j.jctube.2019.100141
Autor:
Larisa V. Yurchenko, Galyna A Kutsyna, Natalia D Prihoda, Svetlana I Zaitzeva, Jirathitikal, Tetyana Butova, Aldar S. Bourinbaiar, Yuri V Efremenko, Dmytro Butov, Anna L Stepanenko, Nina I. Sokolenko
Publikováno v:
Immunotherapy. 5:1047-1054
Aim: A 1-month Phase II trial was conducted in 41 patients with pulmonary TB who were randomized into treatment (n = 20) and placebo (n = 21) arms to investigate the safety and efficacy of an orally-administered therapeutic TB vaccine (V7) containing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b27eaf42cfcf626f8727424e035060b
https://doi.org/10.2217/imt.13.110
https://doi.org/10.2217/imt.13.110
Autor:
Svetlana I Zaitzeva, Anna L Stepanenko, Larisa V. Yurchenko, Dmytro Butov, Galyna A Kutsyna, Vichai Jirathitikal, Yuri V Efremenko, Natalia D Prihoda, Tetyana Butova, Nina I. Sokolenko, Aldar S. Bourinbaiar
Publikováno v:
Human Vaccines & Immunotherapeutics. 9:1852-1856
One-month Phase II trial was conducted in 43 sputum smear-positive patients with pulmonary tuberculosis randomized into treatment (n = 22) and placebo (n = 21) arms to investigate the safety and efficacy of an orally-administered therapeutic TB vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81522da283313f14ad56c51b645b73c6
https://doi.org/10.4161/hv.25280
https://doi.org/10.4161/hv.25280
Autor:
Galyna A Kutsyna, Dmytro Butov, Yuri V Efremenko, Nina I. Sokolenko, Larisa I Yurchenko, Svetlana S Zaitzeva, Anna L Stepanenko, Tatiana Butova, Vichai Jirathitikal, Olga V. Arjanova, Natalia D Prihoda, Aldar S. Bourinbaiar
Publikováno v:
Immunotherapy. 4:687-695
Aim: To evaluate the effect of an adjunct immunotherapy in randomized double-blind, placebo-controlled Phase IIb trial involving 123 TB patients. Methods: Patients were randomly allocated into two arms: one (n = 62) received a once-daily pill of V-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888dafed597b374100203a330c4b3e40
https://doi.org/10.2217/imt.12.59
https://doi.org/10.2217/imt.12.59
Autor:
Larisa V. Yurchenko, Valery M. Frolov, Olga V. Arjanova, Svetlana I Zaitzeva, Olga A. Maksimenko, Galyna A Kutsyna, Anna L Stepanenko, Nina I. Sokolenko, Tatyana S. Butova, Elena A. Grinishina, Natalia D Prihoda, Vichai Jirathitikal, Dmitry A Butov, Aldar S. Bourinbaiar
Publikováno v:
Open Journal of Immunology. :50-55
reatment failed TB patients have very limited chances of survival. Open label trial of daily oral pill of V-5 Immunitor (V5) was conducted in 48 treatment-failed TB patients on palliative support consisting of isoniazid (H) and rifampicin (R). The su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f064cf0848c888022132a7a42176da1f
https://doi.org/10.4236/oji.2011.12006
https://doi.org/10.4236/oji.2011.12006
Autor:
Larisa V. Yurchenko, Volodymyr S. Pylypchuk, Valery M. Frolov, Galyna A Kutsyna, Olga V. Arjanova, Lyudmila A. Vihrova, Nina I. Sokolenko, Natalia D Prihoda
Publikováno v:
Immunotherapy. 1:549-556
Immunoxel (Dzherelo™) is an oral, herbal immunomodulator used in Ukraine for adjunct therapy of infectious and autoimmune diseases. Antiretroviral drug-naive, tuberculosis (TB)/HIV coinfected patients with active pulmonary TB were divided into two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc140e19681c807465cd1f0a873cedd7
https://doi.org/10.2217/imt.09.25
https://doi.org/10.2217/imt.09.25
Autor:
Natalia D Prihoda, Larisa V. Yurchenko, Jirathitikal, Galyna A Kutsyna, Arjanova Ov, Tetyana Butova, Anna L Stepanenko, Bourinbaiar As, Svetlana I Zaitzeva, Dmytro Butov, Nina I. Sokolenko
Publikováno v:
Mycobacterial Diseases.
Open label phase 2b retrospectively controlled trial was conducted in 72 treatment-failed TB patients on socalled palliative support consisting of isoniazid (H) and rifampicin (R) with or without adjunct immunotherapy. The intervention group (N=36) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d852b67601069bc5ca574774238d1e3
https://doi.org/10.4172/2161-1068.s1-001
https://doi.org/10.4172/2161-1068.s1-001
Autor:
John L Rowe, Galyna A Kutsyna, Vichai Jirathitikal, Nina I. Sokolenko, Volodymyr S. Pylypchuk, Igor V Mospan, Natalia D Prihoda, Olga V. Arjanova, Yuri V Efremenko, Aldar S. Bourinbaiar, Larisa V. Yurchenko
Publikováno v:
Immunotherapy. 4(3)
Immunoxel (Dzherelo) is a water–alcohol extract of medicinal plants used in Ukraine as an adjunct immunotherapy to TB and HIV therapy. Four types of solid sublingual formulations of Immunoxel were made: sugar dragées, sugar-coated pills, gelatin p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd1da79dfe598517019e84bf3fb3bdf
https://pubmed.ncbi.nlm.nih.gov/22401633
https://pubmed.ncbi.nlm.nih.gov/22401633